![]() ![]() However, the most utilized mammalian host systems, namely Chinese hamster ovary (CHO), Sp2/0 and NS0 mouse myeloma cells, can produce glycoproteins with non-human glycans that may potentially illicit immunogenic responses. John Wiley & Sons, Inc, Hoboken, NJįletcher T (2005) Designing culture media for recombinant protein production: a rational approach.Mammalian host cell lines are the preferred expression systems for the manufacture of complex therapeutics and recombinant proteins. In: Flickinger MC (ed) Encyclopedia of industrial biotechnology, bioprocess, bioseparation, and cell technology. Vijayasankaran N, Li J, Shawley R, Chen A, Shiratori M, Gawlitzek M (2010) Animal cell culture media. Kildegaard HF, Fan Y, Sen JW, Larsen B, Andersen MR (2016) Glycoprofiling effects of media additives on IgG produced by CHO cells in fed-batch bioreactors. doi: 10.1038/nbt1026įan Y, Jimenez Del Val I, Muller C, Wagtberg Sen J, Rasmussen SK, Kontoravdi C, Weilguny D, Andersen MR (2015) Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. ![]() Gonzalez-Leal IJ, Carrillo-Cocom LM, Ramirez-Medrano A, Lopez-Pacheco F, Bulnes-Abundis D, Webb-Vargas Y, Alvarez MM (2011) Use of a Plackett-Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells. Lopes JA, Costa PF, Alves TP, Menezes JC (2004) Chemometrics in bioprocess engineering: process analytical technology (PAT) applications. Xie L, Wang DI (1994) Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor. Xie L, Wang DI (1994) Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. doi: 10.3390/bioengineering1040188įike R (2009) Nutrient supplementation strategies for biopharmaceutical production, part 1: Identifying a formulation. Gronemeyer P, Ditz R, Strube J (2014) Trends in upstream and downstream process development for antibody manufacturing. Jordan M, Voisard D, Berthoud A, Tercier L, Kleuser B, Baer G, Broly H (2013) Cell culture medium improvement by rigorous shuffling of components using media blending. Kim SH, Lee GM (2009) Development of serum-free medium supplemented with hydrolysates for the production of therapeutic antibodies in CHO cell cultures using design of experiments. Zhang H, Wang H, Liu M, Zhang T, Zhang J, Wang X, Xiang W (2013) Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody. Springer, Londonīirch JR, Racher AJ (2006) Antibody production. In: Oxender DL, Post LE (eds) Modern biotechnology: from laboratory to human testing. Marcus-Sekura C, Kozak R (1999) Continuous cell lines and contaminant testing in novel therapeutics. Kurz M (2007) Upstream processing: regulatory considerations regarding quality aspects of monoclonal antibodies. Kim JY, Kim YG, Lee GM (2012) CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Yu M, Hu Z, Pacis E, Vijayasankaran N, Shen A, Li F (2011) Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process. Jayapal K, Wlaschin K, Yap M, Hu W (2007) Recombinant protein therapeutics from CHO cells – 20 years and counting. Reinhart D, Damjanovic L, Kaisermayer C, Kunert R (2015) Benchmarking of commercially available CHO cell culture media for antibody production. Hossler P, Khattak SF, Li ZJ (2009) Optimal and consistent protein glycosylation in mammalian cell culture. ![]() doi: 10.1007/s1061-xĬosta AR, Rodrigues ME, Henriques M, Oliveira R, Azeredo J (2014) Glycosylation: impact, control and improvement during therapeutic protein production. doi: 10.1038/nbt.3040īutler M (2006) Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems. Walsh G (2014) Biopharmaceutical benchmarks 2014. Wurm F (2013) CHO quasispecies-implications for manufacturing processes. Urlaub G, Kas E, Carothers AM, Chasin LA (1983) Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Urlaub G, Chasin LA (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Hamilton WG, Ham RG (1977) Clonal growth of chinese hamster cell lines in protein-free media. Long-term cultivation of euploid cells from human and animal subjects. Puck TT, Cieciura SJ, Robinson A (1958) Genetics of somatic mammalian cells. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |